NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its revenues for the first quarter of fiscal year 2019 fell 21 percent year over year.

For the three months ended Oct. 31, the firm reported total revenues of $21.3 million, down from $26.9 million in Q1 2018.